Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 46% ± 20% | |
plasma cell | 5 studies | 27% ± 11% | |
ciliated cell | 4 studies | 24% ± 8% | |
epithelial cell | 4 studies | 37% ± 13% | |
goblet cell | 4 studies | 31% ± 17% | |
plasmablast | 3 studies | 32% ± 12% | |
cardiac muscle cell | 3 studies | 20% ± 3% | |
microglial cell | 3 studies | 23% ± 4% | |
oligodendrocyte | 3 studies | 20% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 6341.20 | 245 / 245 | 100% | 64.24 | 501 / 502 |
thymus | 100% | 7086.87 | 653 / 653 | 99% | 26.57 | 600 / 605 |
kidney | 100% | 7183.37 | 89 / 89 | 98% | 30.21 | 884 / 901 |
brain | 99% | 5928.92 | 2622 / 2642 | 97% | 34.42 | 686 / 705 |
intestine | 100% | 5899.25 | 966 / 966 | 96% | 31.37 | 505 / 527 |
stomach | 100% | 8909.75 | 359 / 359 | 94% | 32.51 | 269 / 286 |
pancreas | 100% | 6228.52 | 328 / 328 | 93% | 20.27 | 165 / 178 |
breast | 99% | 3114.91 | 453 / 459 | 91% | 24.62 | 1012 / 1118 |
skin | 94% | 3286.71 | 1704 / 1809 | 94% | 30.40 | 446 / 472 |
esophagus | 99% | 4537.54 | 1428 / 1445 | 89% | 23.35 | 163 / 183 |
lung | 100% | 4442.84 | 576 / 578 | 88% | 22.32 | 1018 / 1155 |
bladder | 100% | 3298.24 | 21 / 21 | 79% | 17.80 | 400 / 504 |
ovary | 100% | 5087.85 | 180 / 180 | 73% | 11.09 | 315 / 430 |
uterus | 100% | 4469.27 | 170 / 170 | 71% | 14.16 | 328 / 459 |
adrenal gland | 94% | 1747.12 | 243 / 258 | 27% | 9.58 | 61 / 230 |
spleen | 100% | 6701.10 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3377.65 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 7054.25 | 854 / 861 | 0% | 0 | 0 / 0 |
adipose | 98% | 2634.65 | 1183 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 26.69 | 44 / 45 |
muscle | 96% | 4735.14 | 774 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 14.25 | 70 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 15.29 | 25 / 29 |
liver | 48% | 1168.24 | 109 / 226 | 36% | 6.33 | 146 / 406 |
peripheral blood | 78% | 2091.40 | 726 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019413 | Biological process | acetate biosynthetic process |
GO_0006085 | Biological process | acetyl-CoA biosynthetic process |
GO_0019542 | Biological process | propionate biosynthetic process |
GO_0019427 | Biological process | acetyl-CoA biosynthetic process from acetate |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0003987 | Molecular function | acetate-CoA ligase activity |
GO_0016208 | Molecular function | AMP binding |
GO_0050218 | Molecular function | propionate-CoA ligase activity |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | ACSS1 |
Protein name | Acyl-CoA synthetase short chain family member 1 Acetyl-coenzyme A synthetase (EC 6.2.1.1) acetate--CoA ligase (EC 6.2.1.1) Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17) |
Synonyms | ACAS2L KIAA1846 |
Description | FUNCTION: Catalyzes the synthesis of acetyl-CoA from short-chain fatty acids . Acetate is the preferred substrate . Can also utilize propionate with a much lower affinity (By similarity). Provides acetyl-CoA that is utilized mainly for oxidation under ketogenic conditions (By similarity). Involved in thermogenesis under ketogenic conditions, using acetate as a vital fuel when carbohydrate availability is insufficient (By similarity). . |
Accessions | ENST00000323482.9 [Q9NUB1-1] ENST00000432802.6 [Q9NUB1-4] ENST00000376726.3 Q7Z5G3 Q1RMZ4 Q9NUB1 ENST00000537502.5 [Q9NUB1-3] Q5TF43 |